Deciphering LY6G6D - An Emerging Target in Colorectal Cancer
Colorectal cancer (CRC) is recognized as one of the most common and life-threatening malignancies, with...
Feb 07, 2024
Focusing on the Neuroendocrine Tumor Target SEZ6
Neuroendocrine neoplasms/tumors (NENs or NETs) are rare tumors that originate from specialized cells called neuroendocrine...
Jan 02, 2024
Butyrophilin (BTN) family: γδ T Cell Receptor Ligands, Immunomodulators and More
Immunotherapy is an essential option for current disease treatment. However, most patients fail to respond...
Dec 27, 2023
The Role of Delta-like Ligand 3 (DLL3) in Targeted Therapy for Cancer
On November 13, 2023, Legend Biotech officially announced that its wholly-owned subsidiary, Legend Biotech Ireland...
Nov 27, 2023
Festival of Biologics in Europe 2023
KACTUS is attending Europe's largest biologics event - Festival of Biologics in Basel, Switzerland October 10-12th! Chat...
Oct 03, 2023
Advancing Breast Cancer Research: Uniting for Progress on World Breast Cancer Research Day 2023
Every year, on August 18th, the world comes together to observe World Breast Cancer Research...
Aug 18, 2023
Exploring the Role of MICA in Tumor Immunity and Targeted Therapies
MICA, also known as MHC Class I Polypeptide-Related Sequence A, is a type I MHC...
Jul 06, 2023